ArticleCell reports2017

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.

Johannes Brägelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.